Stay updated on ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations section now lists Michigan as a study site under Locations. The footer text changed by removing 'HHS Vulnerability Disclosure' and 'Michigan Locations' and the revision tag updated from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T07:38:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision tag v3.3.2 was added and the previous v3.3.1 tag removed, indicating a minor version update with no changes to study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:27:44.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a note in the Publications section stating that PubMed publications are automatically filled and may not pertain to the study, added a Revision: v3.3.1, and removed the older PubMed description and Revision: v3.2.0 text; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:27:37.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Notice about government funding lapse was removed; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:14:17.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The two screenshots show only minor UI tweaks with no changes to core study content, eligibility, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:50:03.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    New operating-status notice and v3.2.0 release; prior v3.1.0 revision removed.
    Difference
    3%
    Check dated 2025-10-05T08:07:13.000Z thumbnail image

Stay in the know with updates to ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABLE: Abraxane + Anti-PD1/PDL1 in Adv Urothelial Cancer Clinical Trial page.